All In Biotech

Drug Trial Radar · NCT03342898

Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) Administered With a Yellow Fever Vaccine in Adults

A Randomized, Observer-Blind, Placebo-Controlled, Phase 3 Trial to Investigate the Immunogenicity and Safety of a Tetravalent Dengue Vaccine Candidate and a Yellow Fever YF-17D Vaccine Administered Concomitantly and Sequentially in Healthy Subjects Aged 18 to 60 Years in Non-Endemic Country(Ies)

Last checked: Nov 19, 2026Latest source record: Oct 8, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 900 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

900

Actual

Start

Feb 28, 2018

Primary completion

May 9, 2018

Study completion May 22, 2019

Sponsor

Lead sponsor
TakedaTakeda (TAK)
Sponsor type
Industry
First posted
Nov 17, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 60 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The main purpose of this study is to assess the immunogenicity and safety of the concomitant and sequential administration of yellow fever (YF) vaccine and tetravalent dengue vaccine (TDV) in healthy participants aged 18 to 60 years living in country non-endemic for both dengue and YF.

Conditions

  • Dengue

Interventions

  • YF-17DBiological

    YF-17D SC injection.

  • TDVBiological

    TDV SC injection.

  • PlaceboDrug

    Normal Saline (0.9% NaCl) SC injection.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Who Are YF and Dengue Virus (DENV)-Naive at Baseline and Are Seroprotected Against YF on Day 30 as Measured by Plaque Reduction Neutralization Test (PRNT)Time frame: Day 30

Locations

11 sites in 1 country. Site status is shown where the registry gives one.

  • Coastal Clinical Research Inc

    Mobile, Alabama

  • Empire Clinical Research

    Pomona, California

  • Advanced Clinical Research

    Meridian, Idaho

  • Johnson County Clin-Trials

    Lenexa, Kansas

  • Center for Pharmaceutical Research

    Kansas City, Missouri

  • Meridian Clinical Research LLC

    Omaha, Nebraska

  • Regional Clinical Research Inc.

    Endwell, New York

  • Rapid Medical Research Inc

    Cleveland, Ohio

  • Tekton Research

    Austin, Texas

  • Advanced Clinical Research

    West Jordan, Utah

  • Clinical Research Associates of Tidewater

    Norfolk, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.